Top 100 Contractors in NAICS 325413: In-Vitro Diagnostic Substance Manufacturing, Aug 2025–Jul 2026

Parent companies by net contract obligations Aug 1, 2025 – Jul 31, 2026 Code page on GovTribe

The latest 12 months. See the newest fiscal year's list: Top Contractors in NAICS 325413: In-Vitro Diagnostic Substance Manufacturing, FY2025.

The top 10 won 60% of NAICS 325413 contract dollars from August 2025 through July 2026

Ranking facts

Contract obligations
$175,458,784 Net of deobligations, by contracts coded NAICS 325413
Contractors
153 Parent companies with an obligation
Largest contractor
Danaher Corporation $39.8 million, 17.7% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV · Free to reuse with credit to GovTribe (CC BY 4.0)

Full ranking

Rank Contractor Net obligations Share Trend
1 $39,751,834
Rank history: #4 in FY2021, #5 in FY2022, #11 in FY2023, #1 in FY2024 and #1 in FY2025; unchanged since Aug 2024–Jul 2025.
2 $29,128,985
Rank history: #85 in FY2021, not on the FY2022–FY2023 lists, #6 in FY2024 and #4 in FY2025; up 8 since Aug 2024–Jul 2025.
3 $23,268,226
Rank history: not on the FY2021–FY2024 lists and #3 in FY2025; up 1 since Aug 2024–Jul 2025.
4 $9,213,159
Rank history: #3 in FY2021, #15 in FY2022, #20 in FY2023, #7 in FY2024 and #6 in FY2025; up 2 since Aug 2024–Jul 2025.
5 $8,023,891
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
6 $7,531,943
Rank history: #1 in FY2021, #2 in FY2022, #3 in FY2023, #38 in FY2024 and #5 in FY2025; down 1 since Aug 2024–Jul 2025.
7 $4,443,100
Rank history: not on the FY2021–FY2023 lists, #67 in FY2024 and #10 in FY2025; up 10 since Aug 2024–Jul 2025.
8 $4,361,131
Rank history: #11 in FY2021, #14 in FY2022, #22 in FY2023, #5 in FY2024 and #7 in FY2025; up 7 since Aug 2024–Jul 2025.
9 $4,132,060
Rank history: #5 in FY2021, #43 in FY2022, #71 in FY2023, #21 in FY2024 and #8 in FY2025; down 1 since Aug 2024–Jul 2025.
10 $3,905,080
Rank history: #85 in FY2021, not on the FY2022–FY2023 lists, #6 in FY2024 and #2 in FY2025; down 7 since Aug 2024–Jul 2025.
11 $3,568,334
Rank history: #52 in FY2021, #54 in FY2022, #47 in FY2023, #37 in FY2024 and #14 in FY2025; up 5 since Aug 2024–Jul 2025.
12 $3,330,499
Rank history: #96 in FY2021, not on the FY2022 list, #77 in FY2023, #82 in FY2024 and #49 in FY2025; up 44 since Aug 2024–Jul 2025.
13 $2,752,588
Rank history: not on the FY2021–FY2023 lists, #64 in FY2024 and #9 in FY2025; down 4 since Aug 2024–Jul 2025.
14 $2,019,999
Rank history: #20 in FY2021, #21 in FY2022, #32 in FY2023, #27 in FY2024 and #16 in FY2025; up 13 since Aug 2024–Jul 2025.
15 $1,933,538
Rank history: not on the FY2021–FY2024 lists and #13 in FY2025; up 3 since Aug 2024–Jul 2025.
16 $1,903,597
Rank history: #15 in FY2021, #29 in FY2022, #29 in FY2023, #17 in FY2024 and #12 in FY2025; down 2 since Aug 2024–Jul 2025.
17 $1,794,913
Rank history: #42 in FY2021, #46 in FY2022, #38 in FY2023, #23 in FY2024 and #15 in FY2025; up 3 since Aug 2024–Jul 2025.
18 $1,792,363
Rank history: not on the FY2021 list, #37 in FY2022 and not on the FY2023–FY2025 lists; up 41 since Aug 2024–Jul 2025.
19 $1,577,272
Rank history: #32 in FY2021, #50 in FY2022, #39 in FY2023, #24 in FY2024 and #19 in FY2025; up 2 since Aug 2024–Jul 2025.
20 $1,512,816
Rank history: not on the FY2021–FY2023 lists, #99 in FY2024 and #18 in FY2025; up 4 since Aug 2024–Jul 2025.
21 $1,505,523
Rank history: #31 in FY2021, #41 in FY2022, #40 in FY2023, #19 in FY2024 and #22 in FY2025; up 8 since Aug 2024–Jul 2025.
22 $1,477,244
Rank history: #9 in FY2021, #6 in FY2022, #28 in FY2023, #22 in FY2024 and not on the FY2025 list; new, not ranked in Aug 2024–Jul 2025.
23 $1,268,377
Rank history: not on the FY2021–FY2024 lists and #35 in FY2025; up 38 since Aug 2024–Jul 2025.
24 $966,586
Rank history: not on the FY2021 list, #33 in FY2022, #36 in FY2023, #25 in FY2024 and #17 in FY2025; up 1 since Aug 2024–Jul 2025.
25 $951,710
Rank history: not on the FY2021 list, #64 in FY2022, #50 in FY2023, #33 in FY2024 and #29 in FY2025; up 11 since Aug 2024–Jul 2025.
26 $882,705
Rank history: #44 in FY2021, #60 in FY2022, #59 in FY2023, #42 in FY2024 and #30 in FY2025; up 15 since Aug 2024–Jul 2025.
27 $865,680
Rank history: #46 in FY2021, not on the FY2022 list, #52 in FY2023, #49 in FY2024 and #24 in FY2025; up 7 since Aug 2024–Jul 2025.
28 $760,000
Rank history: not on the FY2021–FY2024 lists and #39 in FY2025; up 23 since Aug 2024–Jul 2025.
29 $590,478
Rank history: not on the FY2021 list, #90 in FY2022, #89 in FY2023, #87 in FY2024 and #52 in FY2025; up 45 since Aug 2024–Jul 2025.
30 $587,946
Rank history: not on the FY2021–FY2023 lists, #50 in FY2024 and #27 in FY2025; up 16 since Aug 2024–Jul 2025.
31 $554,593
Rank history: #87 in FY2021, #67 in FY2022, #65 in FY2023, #56 in FY2024 and #42 in FY2025; up 40 since Aug 2024–Jul 2025.
32
Grifols Diagnostic Solutions Inc.
$530,071
Rank history: not on the FY2021–FY2023 lists, #74 in FY2024 and #25 in FY2025; up 5 since Aug 2024–Jul 2025.
33 $487,964
Rank history: #43 in FY2021, #47 in FY2022, #51 in FY2023, #34 in FY2024 and #23 in FY2025; up 12 since Aug 2024–Jul 2025.
34 $466,549
Rank history: #75 in FY2021, #70 in FY2022, #75 in FY2023, not on the FY2024 list and #32 in FY2025; up 19 since Aug 2024–Jul 2025.
35 $465,557
Rank history: not on the FY2021–FY2023 lists, #79 in FY2024 and #53 in FY2025; up 37 since Aug 2024–Jul 2025.
36 $446,880
Rank history: not on the FY2021–FY2023 lists, #66 in FY2024 and #40 in FY2025; up 16 since Aug 2024–Jul 2025.
37 $438,476
Rank history: #18 in FY2021, #20 in FY2022, #27 in FY2023, #12 in FY2024 and #11 in FY2025; down 25 since Aug 2024–Jul 2025.
38 $418,098
Rank history: #12 in FY2021, #18 in FY2022, #62 in FY2023, not on the FY2024 list and #62 in FY2025; up 43 since Aug 2024–Jul 2025.
39 $407,985
Rank history: #54 in FY2021, #61 in FY2022, #57 in FY2023, #59 in FY2024 and #41 in FY2025; up 19 since Aug 2024–Jul 2025.
40 $396,000
Rank history: not on the FY2021 list, #71 in FY2022, #35 in FY2023, #29 in FY2024 and #21 in FY2025; down 17 since Aug 2024–Jul 2025.
41 $369,871
Rank history: not on the FY2021–FY2024 lists and #59 in FY2025; new, not ranked in Aug 2024–Jul 2025.
42 $368,925
Rank history: not on the FY2021–FY2024 lists and #26 in FY2025; down 7 since Aug 2024–Jul 2025.
43 $348,390
Rank history: #57 in FY2021, #68 in FY2022, #68 in FY2023, #53 in FY2024 and #38 in FY2025; up 7 since Aug 2024–Jul 2025.
44 $344,246
Rank history: #72 in FY2021, #87 in FY2022, #80 in FY2023, #69 in FY2024 and #50 in FY2025; up 22 since Aug 2024–Jul 2025.
45 $310,777
Rank history: not on the FY2021–FY2024 lists and #99 in FY2025; up 69 since Aug 2024–Jul 2025.
46 $301,824
Rank history: not on the FY2021–FY2024 lists and #90 in FY2025; up 48 since Aug 2024–Jul 2025.
47 $297,959
Rank history: not on the FY2021–FY2023 lists, #72 in FY2024 and #36 in FY2025; up 1 since Aug 2024–Jul 2025.
48 $289,497
Rank history: not on the FY2021–FY2024 lists and #65 in FY2025; up 43 since Aug 2024–Jul 2025.
49 $248,930
Rank history: #50 in FY2021, #77 in FY2022, #81 in FY2023, not on the FY2024 list and #58 in FY2025; new, not ranked in Aug 2024–Jul 2025.
50 $229,357
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
51
Cambridge Isotope Laboratories Inc.
$221,095
Rank history: not on the FY2021–FY2023 lists, #100 in FY2024 and #61 in FY2025; up 73 since Aug 2024–Jul 2025.
52
Biofire Diagnostics LLC
$196,294
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
53 $191,450
Rank history: #10 in FY2021, #59 in FY2022, #9 in FY2023, not on the FY2024 list and #60 in FY2025; up 39 since Aug 2024–Jul 2025.
54 $182,900
Rank history: not on the FY2021–FY2023 lists, #63 in FY2024 and #34 in FY2025; down 16 since Aug 2024–Jul 2025.
55 $182,560
Rank history: #74 in FY2021, #79 in FY2022, #67 in FY2023, #57 in FY2024 and #47 in FY2025; up 8 since Aug 2024–Jul 2025.
56 $177,032
Rank history: #93 in FY2021, not on the FY2022–FY2023 lists, #80 in FY2024 and #75 in FY2025; up 42 since Aug 2024–Jul 2025.
57 $172,740
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
58 $158,912
Rank history: not on the FY2021–FY2023 lists, #85 in FY2024 and #81 in FY2025; up 59 since Aug 2024–Jul 2025.
59 $155,000
Rank history: not on the FY2021 list, #8 in FY2022, #10 in FY2023 and not on the FY2024–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
60 $153,229
Rank history: #16 in FY2021, #35 in FY2022, #46 in FY2023, #52 in FY2024 and #54 in FY2025; down 13 since Aug 2024–Jul 2025.
61 $146,995
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
62 $142,777
Rank history: not on the FY2021–FY2022 lists, #42 in FY2023, not on the FY2024 list and #74 in FY2025; up 6 since Aug 2024–Jul 2025.
63
Laboratory Corporation of America 2 awardees, including Medtox Diagnostics, Inc.
$133,768
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
64 $133,351
Rank history: not on the FY2021–FY2023 lists, #70 in FY2024 and #44 in FY2025; down 2 since Aug 2024–Jul 2025.
65 $129,000
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
66 $125,244
Rank history: not on the FY2021–FY2025 lists; up 120 since Aug 2024–Jul 2025.
67 $124,486
Rank history: not on the FY2021 list, #85 in FY2022 and not on the FY2023–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
68 $123,500
Rank history: not on the FY2021–FY2023 lists, #86 in FY2024 and #46 in FY2025; down 13 since Aug 2024–Jul 2025.
69 $123,390
Rank history: #84 in FY2021 and not on the FY2022–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
70
Idexx Distribution, Inc.
$120,583
Rank history: not on the FY2021–FY2025 lists; up 41 since Aug 2024–Jul 2025.
71
Sysmex Deutschland GMBH
$120,115
Rank history: #23 in FY2021, #27 in FY2022, #31 in FY2023, #14 in FY2024 and not on the FY2025 list; up 67 since Aug 2024–Jul 2025.
72 $116,573
Rank history: not on the FY2021–FY2024 lists and #83 in FY2025; up 28 since Aug 2024–Jul 2025.
73 $112,972
Rank history: not on the FY2021–FY2022 lists, #98 in FY2023 and not on the FY2024–FY2025 lists; up 70 since Aug 2024–Jul 2025.
74 $111,196
Rank history: not on the FY2021–FY2024 lists and #84 in FY2025; up 16 since Aug 2024–Jul 2025.
75
Biocartis US Inc
$108,922
Rank history: not on the FY2021–FY2025 lists; up 45 since Aug 2024–Jul 2025.
76 $106,888
Rank history: not on the FY2021–FY2024 lists and #93 in FY2025; up 60 since Aug 2024–Jul 2025.
77 $99,813
Rank history: not on the FY2021–FY2024 lists and #100 in FY2025; up 41 since Aug 2024–Jul 2025.
78 $94,080
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
79 $92,205
Rank history: not on the FY2021–FY2024 lists and #80 in FY2025; up 20 since Aug 2024–Jul 2025.
80 $91,425
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
81 $91,250
Rank history: not on the FY2021–FY2024 lists and #77 in FY2025; up 28 since Aug 2024–Jul 2025.
82 $88,670
Rank history: #73 in FY2021, #97 in FY2022, #86 in FY2023, #65 in FY2024 and #57 in FY2025; down 4 since Aug 2024–Jul 2025.
83 $87,187
Rank history: not on the FY2021–FY2024 lists and #70 in FY2025; up 39 since Aug 2024–Jul 2025.
84 $81,803
Rank history: not on the FY2021–FY2025 lists; up 18 since Aug 2024–Jul 2025.
85 $80,115
Rank history: not on the FY2021–FY2025 lists; up 57 since Aug 2024–Jul 2025.
86 $77,360
Rank history: not on the FY2021–FY2024 lists and #78 in FY2025; up 9 since Aug 2024–Jul 2025.
87 $72,188
Rank history: #55 in FY2021, not on the FY2022 list, #90 in FY2023 and not on the FY2024–FY2025 lists; up 39 since Aug 2024–Jul 2025.
88 $71,019
Rank history: not on the FY2021–FY2023 lists, #96 in FY2024 and #64 in FY2025; down 23 since Aug 2024–Jul 2025.
89 $66,316
Rank history: not on the FY2021–FY2025 lists; up 43 since Aug 2024–Jul 2025.
90 $65,599
Rank history: #22 in FY2021, #3 in FY2022, #24 in FY2023, #8 in FY2024 and not on the FY2025 list; up 47 since Aug 2024–Jul 2025.
91 $64,400
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
92 $62,066
Rank history: not on the FY2021 list, #9 in FY2022, #16 in FY2023 and not on the FY2024–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
93 $61,799
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
94 $57,435
Rank history: not on the FY2021–FY2025 lists; up 29 since Aug 2024–Jul 2025.
95 $56,356
Rank history: not on the FY2021–FY2025 lists; up 50 since Aug 2024–Jul 2025.
96 $54,983
Rank history: not on the FY2021–FY2025 lists; new, not ranked in Aug 2024–Jul 2025.
97 $54,079
Rank history: not on the FY2021–FY2024 lists and #85 in FY2025; up 15 since Aug 2024–Jul 2025.
98
KKR & Co. Inc. Through Biosearch Technologies, Inc.
$50,968
Rank history: not on the FY2021–FY2022 lists, #72 in FY2023, #39 in FY2024 and not on the FY2025 list; down 65 since Aug 2024–Jul 2025.
99
Lonza Walkersville Inc.
$48,493
Rank history: not on the FY2021–FY2023 lists, #94 in FY2024 and #97 in FY2025; up 6 since Aug 2024–Jul 2025.
100
Fresenius Medical Care Holdings Inc. Through Fenwal, Inc.
$48,356
Rank history: not on the FY2021–FY2025 lists; up 21 since Aug 2024–Jul 2025.
Show 75 more

100 of 153 contractors listed here. See the rest on GovTribe.

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $225 million obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. An awardee whose own actions mostly name no parent, and that no other company's actions name as their parent, rolls up its SAM.gov registration's chain of parent companies: it counts under the first company there that other companies' actions name as their parent, or under the parent most of a company's own actions name, whichever comes first; with neither, under the highest company in the chain with federal contracts of its own. Joint ventures stay companies of their own. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Period: the trailing 12 months end with the last month that ended at least 90 days ago, because the Department of Defense reports its contract actions to FPDS about 90 days late. The list is rebuilt each night.
  • Rank changes compare with Aug 2024–Jul 2025. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 NAICS 325413 contractors in Aug 2025–Jul 2026?

1. Danaher Corporation ($39.8M), 2. Biomerieux Inc. ($29.1M), 3. Roche Holdings Inc. ($23.3M), 4. Thermo Fisher Scientific Inc. ($9.21M), 5. Quest Diagnostics Incorporated ($8.02M), 6. Abbott Laboratories Inc. ($7.53M), 7. Diasorin S.P.A. ($4.44M), 8. Hologic, Inc. ($4.36M), 9. Ortho-Clinical Diagnostics Inc. ($4.13M), 10. Biofire Defense LLC ($3.91M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work